Notice of Intent to Sole Source - Roche Blood Gas Reagents

Notice of Intent to Award Sole Source

The Regional Health Contracting Office-Europe intends to award a Firm Fixed-Price sole source Contract to Roche Diagnostics Corporation, under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i)-Only One Source Reasonably available (e.g., urgency, exclusive licensing agreement, brand name or industrial mobilization) for the Madigan Army Medical Center, Joint Base Lewis-McChord, Tacoma, WA FDA-approved blood gas reagents and consumable supplies to be used with a government owned Roche b211 blood gas analyzers. The applicable NAICS code for this requirement is 325413–"In-Vitro Diagnostic Substance Manufacturing". The Small Business Size Standard is 1,250 employees.

This notice is not a request for competitive quotes. All responsible sources may submit a capability statement, which shall be considered by the agency before the intended award date.  Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government.
 

NOTE:  INTERESTED VENDORS, PLEASE RESPOND TO THIS NOTICE ON OR BEFORE 17 AUGUST 2022, 10:00AM, CEST.

The Region Health Contracting Office-Europe intends to make a sole source award to Roche Diagnostics Corporation, 9115 Hague Rd, Indianapolis, IN 46256-1025. Interested parties may email any concerns to Hyun Townsley at hyun.j.townsley.civ@mail.mil no later than 17 August 2022 at 10:00 am, CEST.